ISSY LES MOULINEAUX
France
50
2021-08-26
46
2025-02-18
These are the the leading inventors for applications assigned to PHARNEXT:
PHARNEXT based in ISSY LES MOULINEAUX, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Early treatment of CMT disease
#2 | 2020-04-30 β Patent 10,736,876 granted on 2020-08-11Idalopirdine-based combinatorial therapies of Alzheimer's disease
#3 | 2020-01-30 β Patent 10,940,147 granted on 2021-03-09Early treatment of CMT disease
#4 | 2019-09-26 β Patent 10,849,851 granted on 2020-12-01Stable oral solutions for combined API
#5 | 2019-06-13 β Patent 10,682,342 granted on 2020-06-16Compositions for treating amyotrophic lateral sclerosis
#6 | 2019-04-18 β Patent 10,799,499 granted on 2020-10-13Combinatorial therapies of neurological disorders
#7 | 2019-01-10 β Patent 10,596,160 granted on 2020-03-24Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
#8 | 2018-12-20 β Patent 10,441,558 granted on 2019-10-15Therapeutic approaches for treating CMT and related disorders
#9 | 2018-12-06 β Patent 10,342,784 granted on 2019-07-09Compositions for treating amyotrophic lateral sclerosis
#10 | 2018-11-29 β Patent 10,434,109 granted on 2019-10-08Compositions for treating neurological disorders
#11 | 2018-11-29 β Patent 10,463,640 granted on 2019-11-05Therapeutic approaches for treating CMT and related disorders
#12 | 2018-09-20THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
#13 | 2018-09-06 β Patent 10,905,686 granted on 2021-02-02Compositions for treating CMT and related disorders
#14 | 2018-09-06 β Patent 10,322,101 granted on 2019-06-18Therapeutic approaches for treating CMT and related disorders
#15 | 2018-04-05 β Patent 10,265,304 granted on 2019-04-23Nootropic compositions for improving memory performance
#16 | 2018-01-04 β Patent 10,383,870 granted on 2019-08-20Early treatment of CMT disease
#17 | 2017-09-28 β Patent 10,342,768 granted on 2019-07-09Therapeutic approaches for treating Parkinson's disease
#18 | 2017-06-15 β Patent 10,583,135 granted on 2020-03-10Compositions for treating CMT and related disorders
#19 | 2017-02-23COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETIC NEUROPATHIES
#20 | 2016-12-08 β Patent 9,566,275 granted on 2017-02-14Compositions for treating CMT and related disorders
#21 | 2016-12-08 β Patent 10,905,672 granted on 2021-02-02Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disorders
#22 | 2016-09-15 β Patent 9,427,436 granted on 2016-08-30Compositions for treating CMT and related disorders
#23 | 2016-08-18 β Patent 10,617,689 granted on 2020-04-14Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
#24 | 2016-07-21 β Patent 9,931,326 granted on 2018-04-03Composition comprising torasemide and baclofen for treating neurological disorders
#25 | 2016-07-07 β Patent 10,010,515 granted on 2018-07-03Therapeutic approaches for treating Parkinson's disease
#26 | 2016-05-19 β Patent 10,045,971 granted on 2018-08-14Compositions for treating amyotrophic lateral sclerosis
#27 | 2016-04-28 β Patent 10,300,015 granted on 2019-05-28Stable oral solutions for combined API
#28 | 2016-01-07 β Patent 9,636,316 granted on 2017-05-02Baclofen and acamprosate based therapy of neurological disorders
#29 | 2015-12-31THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
#30 | 2015-10-22 β Patent 9,945,876 granted on 2018-04-17Diagnostic tools for charcot-marie-tooth disease
#31 | 2015-09-03 β Patent 10,004,744 granted on 2018-06-26Therapeutic approaches for treating Parkinson's disease
#32 | 2015-08-27 β Patent 9,545,389 granted on 2017-01-17Baclofen and acamprosate based therapy of macular degeneration disorders
#33 | 2015-08-20 β Patent 10,092,554 granted on 2018-10-09Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
#34 | 2015-08-13 β Patent 9,789,098 granted on 2017-10-17Nootropic compositions for improving memory performance
#35 | 2014-12-25 β Patent 9,144,558 granted on 2015-09-29Baclofen and acamprosate based therapy of neurological disorders
#36 | 2014-12-18 β Patent 9,241,933 granted on 2016-01-26Compositions for treating amyotrophic lateral sclerosis
#37 | 2014-12-18 β Patent 9,248,111 granted on 2016-02-02Therapeutic approaches for treating parkinson's disease
#38 | 2014-12-04 β Patent 9,387,206 granted on 2016-07-12Therapeutic approaches for treating Alzheimer's disease
#39 | 2014-08-21 β Patent 9,597,297 granted on 2017-03-21Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
#40 | 2014-06-26 β Patent 9,393,241 granted on 2016-07-19Compositions for treating CMT and related disorders
#41 | 2014-03-20 β Patent 9,820,978 granted on 2017-11-21Treatment of cerebral ischemia
#42 | 2014-02-06 β Patent 9,867,837 granted on 2018-01-16Compositions for treating neurological disorders
#43 | 2013-08-22 β Patent 9,494,605 granted on 2016-11-15Diagnostic tools for charcot-marie-tooth disease
#44 | 2013-04-11 β Patent 8,741,886 granted on 2014-06-03Baclofen and acamprosate based therapy of neurological disorders
#45 | 2013-04-04 β Patent 8,865,769 granted on 2014-10-21Baclofen and acamprosate based therapy of neurological disorders
#46 | 2012-11-08 β Patent 9,493,834 granted on 2016-11-15Method for detecting a panel of biomarkers
#47 | 2012-10-25 β Patent 8,809,302 granted on 2014-08-19Therapeutic approaches for treating alzheimer'S disease
#48 | 2012-05-03 β Patent 8,642,566 granted on 2014-02-04Therapeutic approaches for treating neuroinflammatory conditions
#49 | 2012-04-12COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS
#50 | 2012-02-16 β Patent 8,716,269 granted on 2014-05-06Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disorders
Also check out Pharnext's (Issy les Moulineaux, France) applicant profile with 40 patent applications submitted.
16916 β